Blog

Seek truth from facts, competitive symbiosis

scroll down

Announcement on Changes to the Articles of Association and Registered Capital of Hunan Zhengqing Pharmaceutical Group Co., Ltd.

Release time:

2019-06-29

 

Hunan Zhengqing Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company")'s issuance of shares to specific targets (hereinafter referred to as "this private placement") has been approved by the China Securities Regulatory Commission with the "Approval on the Private Placement of Shares by Hunan Zhengqing Pharmaceutical Group Co., Ltd." (CSRC Approval [2019]2023), approving the Company's private placement of no more than 17,964,071 new shares, and including the Company under the supervision of non-listed public companies. The Company completed this private placement in November 2019, issuing a total of 17,964,071 RMB ordinary shares to 2 specific targets, with an issue price of RMB 1.67 per share, and raised funds amounting to RMB 30,000,000, of which the newly added registered capital (share capital) is RMB 17,964,071.

According to the results of this private placement and the authorization of the Company's general meeting of shareholders, the Company amended relevant provisions of its Articles of Association. Article 4 of Chapter 1 was amended to "The Company's registered capital is RMB 70,270,346"; and Article 16 of Chapter 3 was amended to "The total number of shares of the Company is 70,270,346 shares". Currently, the Company has completed the industrial and commercial registration procedures for the amendment of the Articles of Association and the change in registered capital, obtained a new business license, and completed the capital increase registration procedures at Hunan Equity Registration and Management Center Co., Ltd. according to relevant regulations.

This announcement is hereby made.

Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Board of Directors
November 29, 2019